Bladder cancer risk from occupational and environmental exposures

2011

Lopez-Beltran, 2004, Infiltrating urothelial carcinoma, Vol 7, 93

Dietrich, 2001, Ludwig Rehn (1849–1930), World J Urol, 19, 151, 10.1007/s003450100211

McCullough, 1975, Familial transitional cell carcinoma of the bladder, J Urol, 113, 629, 10.1016/S0022-5347(17)59540-3

Lynch, 1987, Familial bladder cancer in an oncology clinic, Cancer Genet Cytogenet, 27, 161, 10.1016/0165-4608(87)90270-6

Kiemeney, 1996, Familial transitional cell carcinoma, J .Urol, 156, 867, 10.1016/S0022-5347(01)65644-1

Mousavi, 2010, Risk of transitional-cell carcinoma of the bladder in first- and second-generation immigrants to Sweden, Eur J Cancer Prev, 19, 275, 10.1097/CEJ.0b013e3283387728

Kiemeney, 1997, Familial transitional cell carcinoma among the population of Iceland, J Urol, 157, 1649, 10.1016/S0022-5347(01)64821-3

Aben, 2006, Segregation analysis of urothelial cell carcinoma, Eur J Cancer, 42, 1428, 10.1016/j.ejca.2005.07.039

Volanis, 2010, Environmental factors and genetic susceptibility promote urinary bladder cancer, Toxicol Lett, 193, 131, 10.1016/j.toxlet.2009.12.018

Horikawa, 2008, Genetic susceptibility to bladder cancer with an emphasis on gene–gene and gene–environmental interactions, Curr Opin Urol, 18, 493, 10.1097/MOU.0b013e32830b88ff

Burch, 1989, Risk of bladder cancer by source and type of tobacco exposure: A case-control study, Int J Cancer, 44, 622, 10.1002/ijc.2910440411

Zeegers, 2000, The impact of characteristics of cigarette smoking on urinary tract cancer risk: A meta-analysis of epidemiologic studies, Cancer, 89, 630, 10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q

Holsti, 1955, Papillary carcinoma of the bladder in mice, obtained after peroral administration of tobacco tar, Cancer, 8, 679, 10.1002/1097-0142(1955)8:4<679::AID-CNCR2820080405>3.0.CO;2-W

Lilienfeld, 1964, The relationship of bladder cancer to smoking, Am J Public Health Nations Health, 54, 1864, 10.2105/AJPH.54.11.1864

2004

Fortuny, 1999, Tobacco, occupation and non-transitional-cell carcinoma of the bladder: An international case-control study, Int J Cancer, 80, 44, 10.1002/(SICI)1097-0215(19990105)80:1<44::AID-IJC9>3.0.CO;2-8

Kantor, 1988, Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder, Cancer Res, 48, 3853

Strope, 2008, The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation, J Urol, 180, 31, 10.1016/j.juro.2008.03.045

Brennan, 2000, Cigarette smoking and bladder cancer in men: A pooled analysis of 11 case-control studies, Int J Cancer, 86, 289, 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M

Fleshner, 1999, Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder, Cancer, 86, 2337, 10.1002/(SICI)1097-0142(19991201)86:11<2337::AID-CNCR23>3.0.CO;2-6

Chen, 2007, Stopping smoking might reduce tumor recurrence in non-muscle-invasive bladder cancer, BJU Int, 100, 281, 10.1111/j.1464-410X.2007.06873.x

Wilhelm-Benartzi, 2011, Association of secondhand smoke exposures with DNA methylation in bladder carcinomas, Cancer Causes Control, 22, 1205, 10.1007/s10552-011-9788-6

McCormack, 2010, Cigar and pipe smoking and cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC), Int J Cancer, 127, 2402, 10.1002/ijc.25252

Pitard, 2001, Cigar, pipe, and cigarette smoking and bladder cancer risk in European men, Cancer Causes Control, 12, 551, 10.1023/A:1011291015233

Alberg, 2007, A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke, Am J Epidemiol, 165, 660, 10.1093/aje/kwk047

Van Hemelrijck, 2009, Secondhand smoking, 4-aminobiphenyl, and bladder cancer: Two meta-analyses, Biomarkers Prev, 18, 1312, 10.1158/1055-9965.EPI-08-0613

Zeegers, 2002, A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands), Cancer Causes Control, 13, 83, 10.1023/A:1013954932343

Jiang, 2007, Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County, Cancer Res, 67, 7540, 10.1158/0008-5472.CAN-07-0048

Hammond, 1993, Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers, J Natl Cancer Inst, 85, 474, 10.1093/jnci/85.6.474

Schorp, 2010, Biomonitoring of smoke constituents: Exposure to 4-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in nonsmokers and smokers, Inhal Toxicol, 22, 725, 10.3109/08958371003717043

2010

Alberg, 2009, Cigarette smoking and bladder cancer: A new twist in an old saga?, J. Natl Cancer Inst, 101, 1525, 10.1093/jnci/djp385

Hirao, 2009, Environmental factors promoting bladder cancer, Curr Opin Urol, 19, 494, 10.1097/MOU.0b013e32832eb4ef

Tsukino, 2004, Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer, J Cancer Res Clin Oncol, 130, 99, 10.1007/s00432-003-0512-0

Moore, 2011, GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: Results from the New England bladder cancer study and NAT2 meta-analysis, Carcinogenesis, 32, 182, 10.1093/carcin/bgq223

Hein, 2002, Molecular genetics and function of NAT1 and NAT2: Role in aromatic amine metabolism and carcinogenesis, Mutat Res, 506, 7507

Bell, 1993, Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer, J Natl Cancer Inst, 85, 1159, 10.1093/jnci/85.14.1159

Hung, 2004, GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population, Int J Cancer, 110, 598, 10.1002/ijc.20157

1981

Bartsch, 1990, Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers, J Natl Cancer Inst, 82, 1826, 10.1093/jnci/82.23.1826

Granella, 1996, Excretion of mutagens, nicotine, and its metabolites in urine of cigarette smokers, Mutagenesis, 11, 207, 10.1093/mutage/11.2.207

Case, 1954, Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry, Br J Ind Med, 11, 75

Carreón, 2010, Increased bladder cancer risk among workers exposed to o-toluidine and aniline: A reanalysis, Occup Environ Med, 67, 348, 10.1136/oem.2009.051136

Pira, 2010, Bladder cancer mortality of workers exposed to aromatic amines: A 58-year follow-up, J Natl Cancer Inst, 102, 1096, 10.1093/jnci/djq214

Ward, 1996, Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess, J Natl Cancer Inst, 88, 1046, 10.1093/jnci/88.15.1046

Dolin, 1992, A descriptive study of occupation and bladder cancer in England and Wales, Br J Cancer, 65, 476, 10.1038/bjc.1992.96

Viel, 1995, Bladder cancer among French farmers: Does exposure to pesticides in vineyards play a part?, Occup Environ Med, 52, 587, 10.1136/oem.52.9.587

Budnick, 1984, Cancer and birth defects near the Drake Superfund site, Pennsylvania, Arch Environ Health, 39, 409, 10.1080/00039896.1984.10545873

Cassidy, 2003, The Drake Health Registry Study: Cause-specific mortality experience of workers potentially exposed to beta-naphthylamine, Am J Ind Med, 44, 282, 10.1002/ajim.10268

Freudenthal, 1994, A re-examination of the cause of excess bladder cancers in chemical plant workers, J Natl Cancer Inst, 86, 59, 10.1093/jnci/86.1.59

Case, 1954, Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry, Br J Ind Med, 11, 213

Melick, 1955, The first reported cases of human bladder tumors due to a new carcinogen-xenylamine, J Urol, 74, 760, 10.1016/S0022-5347(17)67344-0

Baan, 2008, Carcinogenicity of some aromatic amines, organic dyes, and related exposures, Lancet Oncol, 9, 322, 10.1016/S1470-2045(08)70089-5

Swaminathan, 1996, Neoplastic transformation and DNA-binding of 4,4'-methylenebis(2-chloroaniline) in SV40-immortalized human uroepithelial cell lines, Carcinogenesis, 17, 857, 10.1093/carcin/17.4.857

Harling, 2010, Bladder cancer among hairdressers: Ameta-analysis, Occup Environ Med, 67, 351, 10.1136/oem.2009.050195

Takkouche, 2009, Risk of cancer among hairdressers and related workers: A meta-analysis, Int J Epidemiol, 38, 1512, 10.1093/ije/dyp283

Koutros, 2011, Hair dye use and risk of bladder cancer in the New England bladder cancer study, Int J Cancer, 10.1002/ijc.26245

Bolt, 2007, The debate on carcinogenicity of permanent hair dyes: New insights, Crit Rev Toxicol, 37, 521, 10.1080/10408440701385671

Wu, 1961, Epidemiologic studies on blackfoot disease, Memoirs College Med Natl Taiwan Univ, 33

Chen, 1986, A retrospective study on malignant neoplasms of bladder, lung, and liver in blackfoot disease endemic area in Taiwan, Br J Cancer, 53, 399, 10.1038/bjc.1986.65

Chiang, 1993, The incidence of bladder cancer in the blackfoot disease endemic area in Taiwan, Br J Urol, 71, 274, 10.1111/j.1464-410X.1993.tb15942.x

Tan, 2008, Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan, BJU Int, 102, 48, 10.1111/j.1464-410X.2008.07565.x

Bates, 1992, Arsenic ingestion and internal cancers: A review, Am J Epidemiol, 135, 462, 10.1093/oxfordjournals.aje.a116313

Hopenhayn-Rich, 1996, Bladder cancer mortality associated with arsenic in drinking water in Argentina, Epidemiology, 7, 117, 10.1097/00001648-199603000-00003

Kuo, 1964, Arsenic content of artesian well water in endemicarea of chronic arsenic poisoning, 20, 7

Meliker, 2010, Lifetime exposure to arsenic in drinking water and bladder cancer: A population-based case-control study in Michigan, USA, Cancer Causes Control, 21, 745, 10.1007/s10552-010-9503-z

Steinmaus, 2003, Case-control study of bladder cancer and drinking water arsenic in the western United States, Am J Epidemiol, 158, 1193, 10.1093/aje/kwg281

Chiou, 2001, Incidence of transitional cell carcinoma and arsenic in drinking water: A follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan, Am J Epidemiol, 153, 411, 10.1093/aje/153.5.411

Mink, 2008, Low-level arsenic exposure in drinking water and bladder cancer: A review and meta-analysis, Regul Toxicol Pharmacol, 52, 299, 10.1016/j.yrtph.2008.08.010

Tchounwou, 2004, Arsenic toxicity, mutagenesis, and carcinogenesis—a health risk assessment and management approach, Mol Cell Biochem, 255, 47, 10.1023/B:MCBI.0000007260.32981.b9

Jomova, 2011, Arsenic: Toxicity, oxidative stress, and human disease, J Appl Toxicol, 31, 95, 10.1002/jat.1649

1989, IARC monographs on the evaluation of carcinogenic risks to humans. Diesel and gasoline engine exhausts and some nitroarenes, IARC Monogr Eval Carcinog Risks Hum, 46, 1

Petersen, 2010, Cancer morbidity among Danish male urban bus drivers: A historical cohort study, Am J Ind Med, 53, 757, 10.1002/ajim.20837

Clavel, 1994, Occupational exposure to polycyclic aromatic hydrocarbons and the risk of bladder cancer: A French case-control study, Int J Epidemiol, 23, 1145, 10.1093/ije/23.6.1145

Bosetti, 2007, Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: A quantitative review to 2005, Ann Oncol, 18, 431, 10.1093/annonc/mdl172

Roger Chou

Straif, 2005, Carcinogenicity of polycyclic aromatic hydrocarbons, Lancet Oncol, 6, 931, 10.1016/S1470-2045(05)70458-7

Colli, 2011, Population densities in relation to bladder cancer mortality rates in America from 1950 to 1994, Int Urol Nephrol, 10.1007/s11255-011-0018-7

Lash, 2001, Hepatic and renal toxicities associated with perchloroethylene, Pharmacol Rev, 53, 177

1995, Dry-cleaning, some chlorinated solvents and other industrial chemicals, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, IARC Monographs, Lyon, France, 63, 33

1995, Tetrachloroethylene, 63, 159

Mundt, 2003, Critical review of the epidemiological literature on occupational exposure to perchloroethylene and cancer, Int Arch Occup Environ Health, 76, 473, 10.1007/s00420-003-0457-2

Thompson, 1994, Cancer incidence in atomic bomb survivors, Radiat Res, 137, S17, 10.2307/3578892

Brown, 2010, A population-based study of subsequent primary malignancies after endometrial cancer: Genetic, environmental, and treatment-related associations, Int J Radiat Oncol Biol Phys, 78, 127, 10.1016/j.ijrobp.2009.07.1692

Chaturvedi, 2007, Second cancers among 104,760 survivors of cervical cancer: Evaluation of long-term risk, J Natl Cancer Inst, 99, 1634, 10.1093/jnci/djm201

Nieder, 2008, Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: A population based cohort study, J Urol, 180, 2005, 10.1016/j.juro.2008.07.038

Coussens, 2002, Inflammation and cancer, Nature, 420, 860, 10.1038/nature01322

Michaud, 2007, Chronic inflammation and bladder cancer, Urol Oncol, 25, 260, 10.1016/j.urolonc.2006.10.002

Rollinson, 2009, A wake up call for urinary schistosomiasis: Reconciling research effort with public health importance, Parasitology, 136, 1593, 10.1017/S0031182009990552

Ferguson, 1911, Associated bilharziasis and primary malignant disease of the urinary bladder with observations on a series of forty cases, J Pathol Bacteriol, 16, 76, 10.1002/path.1700160107

Salem, 2011, Successful control of schistosomiasis and the changing epidemiology of bladder cancer in Egypt, BJU Int, 107, 206, 10.1111/j.1464-410X.2010.09622.x

2006

Gouda, 2007, Bilharziasis and bladder cancer: A time trend analysis of 9843 patients, J Egypt Natl Canc Inst, 19, 158

Botelho, 2009, Urothelial dysplasia and inflammation induced by Schistosoma haematobium total antigen instillation in mice normal urothelium, Urol. Oncol

Locke, 1985, Incidence of squamous cell carcinoma in patients with long-term catheter drainage, J Urol, 133, 1034, 10.1016/S0022-5347(17)49366-9

Pannek, 2002, Transitional cell carcinoma in patients with spinal cord injury: A high risk malignancy?, Urology, 59, 240, 10.1016/S0090-4295(01)01495-9

Hamid, 2003, Screening cystoscopy and biopsy in patients with neuropathic bladder and chronic suprapubic indwelling catheters: Is it valid?, J Urol, 170, 425, 10.1097/01.ju.0000076700.00853.ad

Moody, 2010, Human papillomavirus oncoproteins: Pathways to transformation, Nat Rev Cancer, 10, 550, 10.1038/nrc2886

Noel, 1994, Transitional cell carcinoma of the bladder: Evaluation of the role of human papillomaviruses, Urology, 44, 671, 10.1016/S0090-4295(94)80202-5

Husain, 2009, Human papillomavirus is detected in transitional cell carcinoma arising in renal transplant recipients, Pathology, 41, 245, 10.1080/00313020902756303

Li, 2011, Human papillomavirus infection and bladder cancer risk: A meta-analysis, J Infect Dis, 204, 217, 10.1093/infdis/jir248

Gutiérrez, 2006, Meta-analysis of studies analyzing the relationship between bladder cancer and infection by human papillomavirus, J Urol, 176, 2474, 10.1016/j.juro.2006.07.157

Buzzeo, 1997, Bladder cancer in renal transplant recipients, Urology, 50, 525, 10.1016/S0090-4295(97)00305-1

Vajdic, 2006, Cancer incidence before and after kidney transplantation, JAMA, 296, 2823, 10.1001/jama.296.23.2823

Miao, 2009, De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population, Transplantation, 87, 1347, 10.1097/TP.0b013e3181a238f6

Dietrich, 2009, Glucocorticoid therapy and risk of bladder cancer, Br J Cancer, 101, 1316, 10.1038/sj.bjc.6605314

Worth, 1971, Cyclophosphamide and the bladder, Br Med J, 3, 182, 10.1136/bmj.3.5767.182-a

Pedersen-Bjergaard, 1988, Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma, N Engl J Med, 318, 1028, 10.1056/NEJM198804213181604

Brock, 1982, Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention–III, Eur J Cancer Clin Oncol, 18, 1377, 10.1016/0277-5379(82)90143-2

Travis, 1995, Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma, J Natl Cancer Inst, 87, 524, 10.1093/jnci/87.7.524

Cox, 1979, Cyclophosphamide cystitis—identification of acrolein as the causative agent, Biochem Pharmacol, 28, 2045, 10.1016/0006-2952(79)90222-3

McCarroll, 2008, An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide, Environ Mol Mutagen, 49, 117, 10.1002/em.20372

Bryant, 1980, Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma, Lancet, 2, 657, 10.1016/S0140-6736(80)92703-8

Hensley, 1999, American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants, J Clin Oncol, 17, 3333, 10.1200/JCO.1999.17.10.3333

Johansson, 1974, Uroepithelial tumors of the renal pelvis associated with abuse of phenacetin-containing analgesics, Cancer, 33, 743, 10.1002/1097-0142(197403)33:3<743::AID-CNCR2820330321>3.0.CO;2-M

Johansson, 1979, Carcinogenicity of phenacetin, Science, 204, 130, 10.1126/science.204.4389.130

Fokkens, 1979, Phenacetin abuse related to bladder cancer, Environ Res, 20, 192, 10.1016/0013-9351(79)90097-5

Piper, 1985, Heavy phenacetin use and bladder cancer in women aged 20 to 49 years, N Engl J Med, 313, 292, 10.1056/NEJM198508013130504

Peters, 1999, Role of CYP1A2 in the toxicity of long-term phenacetin feeding in mice, Toxicol Sci, 50, 82, 10.1093/toxsci/50.1.82

Fortuny, 2007, Analgesic and anti-inflammatory drug use and risk of bladder cancer: A population based case control study, BMC Urol, 7, 13, 10.1186/1471-2490-7-13

Fortuny, 2006, Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain, Cancer Epidemiol Biomarkers Prev, 15, 1696, 10.1158/1055-9965.EPI-06-0038

Genkinger, 2007, Nonsteroidal anti-inflammatory drug use and risk of bladder cancer in the health professionals follow-up study, Int J Cancer, 120, 2221, 10.1002/ijc.22546

Lewis, 2011, Risk of bladder cancer among diabetic patients treated with pioglitazone: Interim report of a longitudinal cohort study, Diabetes Care, 34, 916, 10.2337/dc10-1068

Cosyns, 1999, Urothelial lesions in Chinese-herb nephropathy, Am J Kidney Dis, 33, 1011, 10.1016/S0272-6386(99)70136-8

Nortier, 2000, Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi), N Engl J Med, 342, 1686, 10.1056/NEJM200006083422301

Reuber, 1978, Carcinogenicity of saccharin, Environ Health Perspect, 25, 173, 10.1289/ehp.7825173

Takayama, 1998, Long-term feeding of sodium saccharin to nonhuman primates: Implications for urinary tract cancer, J Natl Cancer Inst, 90, 19, 10.1093/jnci/90.1.19

Cohen, 2000, Calcium phosphate-containing precipitate and the carcinogenicity of sodium salts in rats, Carcinogenesis, 21, 783, 10.1093/carcin/21.4.783

Weihrauch, 2004, Artificial sweeteners—do they bear a carcinogenic risk?, Ann Oncol, 15, 1460, 10.1093/annonc/mdh256

Chiu, 2007, Nitrate in drinking water and risk of death from bladder cancer: An ecological case-control study in Taiwan, J Toxicol Environ Health Part A, 70, 1000, 10.1080/15287390601171801

Ward, 2003, Nitrate in public water supplies and risk of bladder cancer, Epidemiology, 14, 183, 10.1097/01.EDE.0000050664.28048.DF

Zeegers, 2006, Nitrate intake does not influence bladder cancer risk: The Netherlands cohort study, Environ Health Perspect, 114, 1527, 10.1289/ehp.9098

Ferrucci, 2010, Meat and components of meat and the risk of bladder cancer in the NIH-AARP Diet and Health Study, Cancer, 116, 4345, 10.1002/cncr.25463

1991, Chlorinated Drinking Water; Chlorination By-Products, Vol 52

2000

Villanueva, 2004, Disinfection byproducts and bladder cancer: A pooled analysis, Epidemiology, 15, 357, 10.1097/01.ede.0000121380.02594.fc

Costet, 2011, Water disinfection by-products and bladder cancer: Is there a European specificity?, Occup Environ Med, 68, 379, 10.1136/oem.2010.062703

Garland, 1980, Do sunlight and vitamin D reduce the likelihood of colon cancer?, Int J Epidemiol, 9, 227, 10.1093/ije/9.3.227

Garland, 1985, Dietary vitamin D and calcium and risk of colorectal cancer: A 19-year prospective study in men, Lancet, 1, 307, 10.1016/S0140-6736(85)91082-7

Mondul, 2010, Serum vitamin D and risk of bladder cancer, Cancer Res, 70, 9218, 10.1158/0008-5472.CAN-10-0985

Brinkman, 2010, Minerals and vitamins and the risk of bladder cancer: Results from the New Hampshire Study, Cancer Causes Control, 21, 609, 10.1007/s10552-009-9490-0

Mohr, 2010, Ultraviolet B irradiance and incidence rates of bladder cancer in 174 countries, Am J Prev Med, 38, 296, 10.1016/j.amepre.2009.10.044

Chen, 2010, Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China, Cancer Causes Control, 21, 1701, 10.1007/s10552-010-9599-1

Nieder, 2008, Florida bladder cancer trends 1981 to 2004: Minimal progress in decreasing advanced disease, J Urol, 179, 491, 10.1016/j.juro.2007.09.082

Resseguie, 1978, Epidemiology of renal and ureteral cancer in Rochester, Minnesota, 1950–1974, with special reference to clinical and pathologic features, Mayo Clin Proc, 53, 503

Botteman, 2003, The health economics of bladder cancer: A comprehensive review of the published literature, Pharmacoeconomics, 21, 1315, 10.2165/00019053-200321180-00003

Nelson, 2002, Unequal treatment: Confronting racial and ethnic disparities in health care, J Natl Med Assoc, 94, 666

Scosyrev, 2009, Sex and racial differences in bladder cancer presentation and mortality in the US, Cancer, 115, 68, 10.1002/cncr.23986

Risch, 1995, Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer, Hum Mol Genet, 4, 231, 10.1093/hmg/4.2.231

Blot, 1978, Geographic patterns of bladder cancer in the United States, J Natl Cancer Inst, 61, 1017

Nieder, 2009, Bladder cancer clusters in Florida: Identifying populations at risk, J Urol, 182, 46, 10.1016/j.juro.2009.02.149

Boulos, 2010, An 8-year snapshot of geospatial cancer research (2002–2009): Clinico-epidemiological and methodological findings and trends, Med Oncol

Langholz, 1999, Latency analysis in epidemiologic studies of occupational exposures: Application to the Colorado Plateau uranium miners cohort, Am J Ind Med, 35, 246, 10.1002/(SICI)1097-0274(199903)35:3<246::AID-AJIM4>3.0.CO;2-6